IRVAX
Price
$25.50
Change
-$0.13 (-0.51%)
Updated
Sep 5 closing price
Net Assets
278.12M
RMFCX
Price
$60.45
Change
+$0.07 (+0.12%)
Updated
Sep 5 closing price
Net Assets
109.34B
Interact to see
Advertisement

IRVAX vs RMFCX

Header iconIRVAX vs RMFCX Comparison
Open Charts IRVAX vs RMFCXBanner chart's image
Voya Russell Large Cap Value Idx Port A
Price$25.50
Change-$0.13 (-0.51%)
VolumeN/A
Net Assets278.12M
American Funds American Mutual R3
Price$60.45
Change+$0.07 (+0.12%)
VolumeN/A
Net Assets109.34B
IRVAX vs RMFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IRVAX vs. RMFCX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRVAX is a Buy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 109B vs. IRVAX (278M). IRVAX pays higher dividends than RMFCX: IRVAX (7.01) vs RMFCX (1.24). IRVAX was incepted earlier than RMFCX: IRVAX (10 years) vs RMFCX (23 years). IRVAX (0.94) and RMFCX (0.91) have similar cost to investors . IRVAX is a more actively managed with annual turnover of: 36.00 vs. RMFCX (31.00). IRVAX has a lower initial minimum investment than RMFCX: IRVAX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 7.71 vs. IRVAX (-11.21). RMFCX return over 5 years is better than : 56.41 vs. IRVAX (39.64).
IRVAXRMFCXIRVAX / RMFCX
Total Expense Ratio0.840.9192%
Annual Report Gross Expense Ratio0.940.91103%
Fund Existence10 years23 years-
Gain YTD-11.92311.421-104%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets278M109B0%
Annual Yield % from dividends7.011.24567%
Returns for 1 year-11.217.71-145%
Returns for 3 years13.7332.1643%
Returns for 5 years39.6456.4170%
Returns for 10 years75.2891.1283%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTAI3.790.22
+6.16%
BioXcel Therapeutics Inc
CAN0.710.02
+3.26%
Canaan
TECH54.411.49
+2.82%
Bio-Techne Corp
KMT21.950.12
+0.55%
Kennametal
HSPOU12.21N/A
N/A
Horizon Space Acquisition I Corp